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Abstract
Dentifrices can augment oral hygiene by inactivating bacteria and at sub-lethal concentra-
tions may affect bacterial metabolism, potentially inhibiting acidogenesis, the main cause of
caries. Reported herein is the development of a rapid method to simultaneously measure
group-specific bactericidal and acidogenesis-mitigation effects of dentifrices on oral bacte-
ria. Saliva was incubated aerobically and anaerobically in Tryptone Soya Broth, Wilkins-
Chalgren Broth with mucin, or artificial saliva and was exposed to dentifrices containing tri-
closan/copolymer (TD); sodium fluoride (FD); stannous fluoride and zinc lactate (SFD1); or
stannous fluoride, zinc lactate and stannous chloride (SFD2). Minimum inhibitory concen-
trations (MIC) were determined turbidometrically whilst group-specific minimum bactericidal
concentrations (MBC) were assessed using growth media and conditions selective for total
aerobes, total anaerobes, streptococci and Gram-negative anaerobes. Minimum acid neu-
tralization concentration (MNC) was defined as the lowest concentration of dentifrice at
which acidification was inhibited. Differences between MIC and MNC were calculated and
normalized with respect to MIC to derive the combined inhibitory and neutralizing capacity
(CINC), a cumulative measure of acidogenesis-mitigation and growth inhibition. The overall
rank order for growth inhibition potency (MIC) under aerobic and anaerobic conditions was:
TD> SFD2> SFD1> FD. Acidogenesis-mitigation (MNC) was ordered; TD> FD> SFD2>
SFD1. CINC was ordered TD> FD> SFD2> SFD1 aerobically and TD> FD> SFD1> SFD2
anaerobically. With respect to group-specific bactericidal activity, TD generally exhibited
the greatest potency, particularly against total aerobes, total anaerobes and streptococci.
This approach enables the rapid simultaneous evaluation of acidity mitigation, growth inhibi-
tion and specific antimicrobial activity by dentifrices.
Introduction
Dental plaque is a taxonomically diverse microbial community, which plays an important role
in oral health and disease [1–3]. The establishment of oral diseases such as dental caries has
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been associated with changes in the taxonomic composition and metabolism of the oral micro-
biota [3], often in response to exogenous factors such as an excess of dietary fermentable sugars
or poor dental hygiene resulting in inadequate plaque control [4,5]. The fermentation of dietary
sugars by oral bacteria produces acids that reduce plaque pH and, if sustained, can demineralize
tooth enamel forming lesions on the tooth surface, resulting in dental caries [6–8]. Evidence sug-
gests that the development of caries is linked to shifts in bacterial community composition and
increased acidogenesis [9–11]. Molecular characterization of the oral microbiota has revealed
that there may be distinct bacterial communities associated with healthy compared to diseased
oral cavities [1, 12], with caries being associated with increases in the abundance of acidogenic
microorganisms including Streptococcus mutans and homofermentative lactobacilli [3, 6].
The control of dental plaque by the routine brushing with dentifrice can improve oral
hygiene, reducing the incidence of oral disease [13,14]. Antimicrobials commonly-used as
adjuncts to oral hygiene such as triclosan [15], zinc citrate and stannous fluoride [16] have
shown marked activity against oral bacteria. Triclosan (2,4,4’-trichloro-2’-hydroxydiphenyl
ether), a chlorinated bisphenol, can inhibit bacterial synthesis of fatty acids at bacteriostatic con-
centrations by interacting with an NADH-dependent enoyl-acyl carrier protein reductase, FabI
[17]. At higher concentrations bactericidal activity has been associated with direct effects on the
bacterial cell membrane [18]. In oral pathogens such as Streptococcus mutans, which lack FabI,
triclosan may also inhibit glycolysis, leading to a reduction in the production of harmful acids
[19]. Zinc salts and stannous fluoride reportedly inhibit bacterial acid production by impairing
glycolysis and carbohydrate fermentation [20,21]. These compounds have growth-inhibitory
properties largely due to inhibitory effects on enzymes required for bacterial metabolism and
growth [20, 21]. The pH of dental plaque is influenced by a variety of factors, most notably by
bacterial acid production, which may be offset to some extent by the buffering effects of saliva
[10]. The mitigation of acid production in saliva and plaque as well as the control of bacterial
growth by dentifrices may therefore be advantageous in the maintenance of oral health.
Several variables are of interest in the pre-clinical assessment of oral care formulations.
From a microbiological perspective these include the extent of bacteriostatic and/or bacteri-
cidal activity, which can be tested with pure or mixed cultures of oral bacteria. Assessing differ-
ential antimicrobial effects on the oral microbiota normally necessitates growing mixed oral
bacteria in various in vitro systems, combined with differential viable counts. Investigating the
functional effects of dentifrices (for example, the inhibition of acidogenesis or proteolysis) at
sub-lethal concentrations is normally achieved (for acidogenesis inhibition) by exposing oral
bacteria to diluted formulations and assessing changes in pH with a microelectrode, or by the
chemical analyses of fermentation acids. Whilst such approaches have proven utility, a rapid
and reproducible endpoint-based method for high-throughput testing of these variables would
be a useful addition to the currently available methodology. Here we report the development of
a method for assessing both acidogenesis-mitigating and antimicrobial effects of dentifrices
against salivary microorganisms.
Materials and Methods
Chemical reagents and bacterial growth media
Chemicals were obtained from Sigma (Dorset, UK) and bacteriological media from Oxoid
(Basingstoke, UK), unless otherwise stated. Bacterial growth media were sterilized at 121°C, 15
psi for 15 min prior to use. The dentifrice formulations evaluated were Colgate1 Total1 (TD),
containing the actives triclosan (0.3% w/v), copolymer (2% w/v) and sodium monofluoropho-
sphate (0.76% w/v); Colgate1 Cavity Protection1 (FD), containing, sodium monofluoropho-
sphate (0.76% w/v); Crest1 Pro-Health1 (SFD1), containing the actives stannous fluoride
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(0.454% w/v) and zinc lactate (2.5% w/v) and Crest1 Pro-Health Clinical1 (SFD2), containing
the actives stannous fluoride (0.454% w/v), zinc lactate stannous chloride (2.5% w/v). Denti-
frices were suspended in sterile broth to produce slurries (50 mg ml-1). Test media included;
artificial saliva (AS), Wilkins Chalgren with 2% mucin (WCM) and Tryptone Soya broth
(TSB). Artificial saliva growth medium (AS) comprised (g/L) in distilled water: Mucin (type II,
porcine, gastric), 2.5; bacteriological peptone, 2.0; tryptone, 2.0; yeast extract, 1.0; NaCl, 0.35;
KCl, 0.2; CaCl2, 0.2; cysteine hydrochloride, 0.1; haemin, 0.001; vitamin K1, 0.0002 [22].
Minimum inhibitory concentrations (MIC)
MICs were determined using the microdilution method as described previously [23]. Briefly,
individual samples of fresh human saliva from 3 healthy volunteers were immediately diluted 1
to 100 in sterile broth (AS, WCM or TSB). Inoculated media (200μL) containing graded con-
centrations of the relevant dentifrice were incubated in the wells of a 96 well microtiter plate at
37°C (24 h) with agitation (100 rpm) in aerobic or anaerobic conditions. Anaerobic conditions
(gas mix: 90% N2, 10% CO2 and 10% H2) were generated using an MG1000 anaerobic worksta-
tion (DonWhitley Scientific, Shipley, UK). The MIC was defined as the lowest concentration
at which bacterial growth was inhibited. Growth was measured as light absorbance (496 nm) in
comparison to an uninoculated well containing the equivalent concentration of dentifrice (neg-
ative control) and was detected using a microtiter plate reader (Powerwave XS, BioTek Instru-
ments, Potton, UK).
Minimum bactericidal concentrations (MBC)
A transferable solid phase screening system (Nunc, Denmark) was used to aseptically transfer
media (approximately 3–4 μL) from the MIC plate wells to a 96 well-plate containing 200 μL of
one of the following bacteriological media; Wilkins Chalgren Agar (with and without anaerobic
Gram-negative supplement) or yeast extract, cysteine, sucrose agar [24] (TYCS; total strepto-
cocci). Plates were incubated at 37°C either aerobically or anaerobically (gas mix: 90% N2, 10%
CO2 and 10% H2; MG1000 anaerobic workstation; Don Whitley Scientific, Shipley, UK). The
MBC was defined as the lowest concentration of dentifrice at which no visible growth occurred
after 3 d of incubation.
Minimum acid neutralizing concentrations (MNC)
Phenol red pH indicator solution (10 μl) was added directly to each MIC plate well after incu-
bation to determine acidification of the growth media. Plates were incubated for a further 15
min at room temperature before determination of colour change. The MNC was defined as the
lowest concentration at which no colour change (red to yellow) occurred. The pH of each den-
tifrice was determined at all test concentrations using a pH meter with a needle electrode (Jen-
way, Staffordshire, UK).
Combined inhibitory neutralizing capacity (CINC)
The CINC was calculated as follows; CINC = (MIC-MNC)/MIC. The CINC therefore provides
a numerical value that represents the cumulative ability of a particular dentifrice to prevent
bacterial acidogenesis below growth inhibitory concentrations in addition to its ability to
completely inhibit bacterial growth. A higher CINC value would therefore indicate better over-
all acid mitigation activity and growth inhibitory activity when compared to a product with a
lower CINC.
Acidogenesis-Mitigation and Bacterial Growth-Inhibition by Dentifrices
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Statistical analysis
Data (MIC, MBC and MNC) were analyzed using a one-way ANOVA (analysis of variance)
and post-hoc Tukey analysis. MICs were directly compared to MNCs for individual formula-
tions using a paired student’s t-test. In both cases P<0.05 was deemed to be statistically
significant.
Ethics statement
Advice was taken from the Chair of a University of Manchester Research Ethics Committee
regarding the correct procedures associated with the use of human saliva samples. The com-
mittee granted exemption from formal ethics approval due to the nature of the work but as
advised, informed written consent was obtained from all volunteers and all samples were col-
lected anonymously.
Results
Specificity of dentifrices for different functional groups of oral bacteria
The bactericidal efficacy of the dentifrice formulations was assessed against total aerobes, total
anaerobes, streptococci and Gram-negative anaerobes. Overall, TD showed significantly
greater bactericidal activity (MBC; 6.3–25 mg/ml) when compared to the other test dentifrices
against total aerobes P<0.05 (Fig 1), while FD, SFD1 and SFD2 demonstrated significantly
higher MBCs of 12.5–25 mg/ml in all test media (and therefore lower potency). TD also exhib-
ited an overall significantly higher bactericidal activity against total anaerobic bacteria
(P<0.05) (Fig 1) with MBC values ranging between 1.6 and 6.3 mg/ml. Comparatively the
potencies of SFD1 (MBC; 3.3–12.5 mg/ml), SFD2 (MBC; 3.3–12.5 mg/ml) and FD (MBC; 4.2–
12.5 mg/ml) were not significantly different against anaerobic bacteria.
When incubated aerobically, MBCs for SFD2 against streptococci ranged between 3.1 and
6.3 mg/ml whilst values for TD ranged between 3.1 and 8.3 mg/ml, both were therefore potent
but there was no statistically significant difference between MBCs for these two formulations
(P>0.05). Equal or lower bactericidal activity against streptococci was observed for SFD1
(MBC; 3.1–12.5 mg/ml) and FD (MBC; 6.3–12.5 mg/ml). Under anaerobic conditions bacteri-
cidal activity against streptococci of TD (MBC; 3.1–5.2 mg/ml) was also significantly higher
(P<0.05) than that of SFD2 (MBC; 3.1–12.5 mg/ml), FD (MBC; 5.2–12.5 mg/ml) and SFD1
(MBC; 6.3–12.5 mg/ml; Fig 1).
Bactericidal activity against Gram-negative anaerobes varied depending on incubation con-
ditions. However, there was no significant difference in activity between all test treatments
with MBC values ranging under aerobic incubation: SFD2 (0.8–3.1 mg/ml), TD (0.8–4.2 mg/
ml), SFD1 (0.8–6.3 mg/ml) and FD (2.1–6.3 mg/ml; Fig 1) and under anaerobic incubation;
TD (MBC; 0.2–3.1 mg/ml) FD (0.2–3.1 mg/ml), SFD1 (1.6–3.1 mg/ml) and SFD2 (1.6–3.1 mg/
ml; Fig 1). Overall, MBCs were lower when tested in TSB when compared to values obtained in
WCM or AS under aerobic conditions whilst MBC were lowest in AS under anaerobic
conditions.
Growth inhibition and acidogenesis-mitigating effects of dentifrices
The inhibit of bacterial growth and acidogenesis by the test pastes was assessed simultaneously
in TSB by determining MICs and MNCs. MNC was defined as the lowest concentration of a
dentifrice that maintained a pH of>7.5 after 24 h, as determined with a pH indicator. The pH
of test dentifrices was determined across the MNC range generating pH values for SFD1 (pH
7.21–7.24), SFD2 (pH 7.22–7.25), FD (pH 7.27–7.24) and TD (pH 7.27–7.25). There was no
Acidogenesis-Mitigation and Bacterial Growth-Inhibition by Dentifrices
PLOS ONE | DOI:10.1371/journal.pone.0149390 February 16, 2016 4 / 10
Fig 1. Minimum group-specific minimumbactericidal concentrations of dentifrices TD (black), FD (grey), SFD1 (white) and SFD2 (hatched) against
salivary microorganisms tested in Tryptone Soya Broth, Wilkins Chalgren Broth with mucin or Artificial Saliva under aerobic or anaerobic
conditions. Data show group-specific bactericidal activity for total aerobes (T-AE), total anaerobes (T-AN), Streptococci (S) and Gram-negative anaerobes
(GN). Error bars represent standard errors for three biological replicates, each with three technical repeats. Statistical significance was determined by
ANOVA with post-hoc Tukey analysis (P<0.05).
doi:10.1371/journal.pone.0149390.g001
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significant difference in pH between the formulations at any test concentration (P<0.05).
MNCs were significantly lower than MICs for both TD and FD (P<0.05) when incubated aero-
bically and for all dentifrices when incubated anaerobically (Fig 2). The rank order of MNC
activity (mg/ml) was TD> FD> SFD2> SFD1 under both aerobic and anaerobic conditions
(Fig 2A), with no significant difference between SFD2 and SFD1 when incubated aerobically
and FD, SFD2 and SFD1 when incubated anaerobically (P<0.05).
The difference between MIC and MNC for each test paste was calculated and normalized
with respect to MIC. The resulting values reflect the combined inhibitory and neutralizing
capacity (CINC) of the test dentifrices, with a high value indicating a good ability to inhibit
both acid production and bacterial growth. The CINC is therefore a single numerical measure
of both specific acidogenesis mitigation and the inhibitory activity of a particular dentifrice
against oral bacteria, providing the means of a clear preclinical measure of the activity of each
test formulation against acidogenic bacteria indicating potential anti-caries activity. The rank
order for CINC was TD> FD> SFD2> SFD1 under aerobic conditions and TD> FD>
SFD1> SFD2 under anaerobic conditions (Fig 3). Whether incubated aerobically or anaerobi-
cally, there was no significant difference between TD and FD, or between SFD1 and SFD1. All
other differences were significant, as calculated by ANOVA with Tukey’s post-hoc analysis
(P<0.05).
Discussion
The use of antimicrobial formulations to control the accumulation of oral bacteria and there-
fore to reduce plaque accumulation can markedly decrease the risk of the development of oral
disease such as caries and gingivitis [14, 25, 26]. Direct bactericidal activity of dentifrices
against oral bacteria is therefore clearly desirable, particularly if the antimicrobial compound
in the dentifrice is effective against bacteria involved in the etiology of oral diseases. The anti-
caries efficacy of a formulation may however be enhanced through specific effects on bacterial
metabolism, including inhibition of the fermentation processes which lead to acid production
[6–8]. In the current study a microtitre plate-based system was used to assess group-specific
bactericidal effects and acidogenesis-mitigation by four dentifrices, TD (containing triclosan/
copolymer), FD (containing sodium monofluorophosphate), SFD1 (containing stannous fluo-
ride and zinc lactate) and SFD2 (containing stannous fluoride, zinc lactate and stannous chlo-
ride). The minimum neutralizing concentration (MNC) and the combined inhibitory and
neutralizing capacity (CINC) are proposed as objective measures by which to quantify specific
effects of dentifrice formulations on bacterial metabolism in relation to acidogenesis-
mitigation.
TD exhibited greatest bactericidal activity against total aerobes and total anaerobes during
MIC testing, prior to plating on selective agars. These findings are in agreement with previous
studies showing the broad-spectrum and high level of antibacterial activity of triclosan [27, 28].
TD also exhibited the highest overall level of bactericidal activity against streptococci when ini-
tially cultured anaerobically. Since the growth environment for plaque is predominantly anaer-
obic, the ability of a dentifrice to inactivate bacteria growing in anaerobic conditions may be
advantageous to oral health. SFD2 demonstrated high overall bactericidal activity against strep-
tococci when cultured aerobically. Previous investigations report the antibacterial activity of
stannous fluoride against oral bacteria [29,30].
TD exhibited greater growth inhibitory effects against bacteria than FD, SFD1 and SFD2.
MNC data also indicate that the test dentifrices inhibited acidogenesis at sub-inhibitory con-
centrations. This may be attributed to specific inhibitory effects on bacterial metabolism and
subsequent acid production. For example, fluoride has been previously shown to inhibit
Acidogenesis-Mitigation and Bacterial Growth-Inhibition by Dentifrices
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sucrose-induced acid production in bacteria [30, 31], potentially accounting for some of the
acidogenesis-mitigating activity observed in this study. However, despite the fact that TD and
FD contain similar concentrations of fluoride, MNC data indicate that the acidogenesis-miti-
gating capability of TD was significantly greater than the other test dentifrices in both aerobic
and anaerobic conditions. Furthermore, TD mitigated acidogenesis at concentrations consider-
ably lower than those required for complete bacterial growth inhibition. Triclosan is known to
function at bacteriostatic concentrations through inhibition of FabI, an enzyme involved in
Fig 2. Minimum inhibitory concentrations (black bars) andminimum neutralizing concentrations (white bars) of test dentifrices (TD, FD, SFD1 and
SFD2) in Tryptone Soya Broth under aerobic and anaerobic conditions. Error bars represent standard errors for three biological replicates, each with
three technical repeats. Asterisks indicate statistically significant differences (p< 0.05) between MIC and MBC determined using a paired Student’s t-test.
doi:10.1371/journal.pone.0149390.g002
Fig 3. The combined inhibitory and neutralizing capacity (CINC) of the test dentifrices (TD, FD, SFD1
and SFD2) in Tryptone Soya Broth under aerobic (black bars) and anaerobic conditions (white bars).
Error bars represent standard error for three biological replicates, each with three technical replicates.
doi:10.1371/journal.pone.0149390.g003
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bacterial fatty acid synthesis [17], as well as through direct effects on the bacterial cytoplasmic
membrane [18]. Importantly, triclosan may inhibit glycolysis and thus acid production in oral
bacteria through inhibition of glycolytic enzymes such as pyruvate kinase, lactic dehydrogenase
and aldolase, as well as via interference in the phosphoenolpyruvate: sugar phosphotransferase
system [32, 33].
Both SFD1 and SFD2 demonstrated lower values for MNC than MIC, particularly when
incubated anaerobically. In addition to stannous fluoride, which has been shown to reduce acid
production in cariogenic bacteria [30, 31], both of these formulations contain zinc, a known
inhibitor of glycolysis providing a plausible explanation for the acidogenesis-mitigating capa-
bilities of these formulations at sub-growth inhibitory concentrations for oral anaerobic bacte-
ria. CINC values facilitated the comparison of the dentifrices on the basis of both their growth
inhibitory effects and the inhibition of acidogenesis at sub-lethal concentrations. When com-
bining the effects of growth-inhibition and acidogenesis-mitigation, TD demonstrated the
highest combined inhibitory and neutralizing capacity (CINC). This is probably due to the bac-
tericidal activity of triclosan, combined with inhibitory effects on bacterial glycolysis [27, 32].
This is a potentially beneficial characteristic of a dentifrice and may partly explain the clinical
efficacy of triclosan-containing dentifrices in reducing plaque. Under aerobic conditions SFD2
demonstrated higher CINC activity than SFD1, due to its lower MNC value. This suggests that
the addition of stannous chloride into dental formulations could increase the acidogenesis
inhibitory activity in oral bacteria.
The capacity of a dentifrice to inhibit plaque acidogenesis is an important property of oral
healthcare formulations. Objective criteria to express the minimum concentration of dentifrice
required to mitigate acidogenesis in controlled conditions (MNC), and the combined inhibi-
tory and neutralizing capacity (CINC) may therefore be used in the pre-clinical evaluation of
dentifrices, enabling acidity mitigation, growth inhibition and specific antimicrobial activity to
be determined simultaneously in a robust and reproducible fashion.
Conclusion
The etiology of dental caries primarily involves acid production by oral bacteria and therefore
the reduction of bacterial acidogensis; whether mediated through the inactivation of bacteria,
the inhibition of bacterial growth or by specific effects on bacterial metabolism, is a desirable
activity for oral health products. In the current investigation a method through which acidity
mitigation, growth inhibition and specific antimicrobial activity can be determined simulta-
neously is described. Test formulations used to evaluate the method exhibited marked differ-
ences in their growth-inhibitory and group-specific bactericidal activities. Acidogenesis-
mitigation was observed at concentrations lower than required for bacterial growth inhibition.
A dentifrice containing triclosan (TD) exhibited a higher level of antimicrobial activity and
acidogenesis-mitigating ability than other test dentifrices.
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